$SCND
SCIENTIFIC INDUSTRIES INC Stock $scnd

$scnd Overview Financials Valuation SEC Filings Company Website

2023 Q3 Form 10-Q Financial Statement

#000165495423010777 Filed on August 14, 2023

Income Statement

Concept	2023 Q3	2023 Q2	2022 Q2
Revenue	$2.586M	$2.983M	$2.777M
YoY Change	-3.16%	7.4%	9.76%
Cost Of Revenue	$1.405M	$1.633M	$1.509M
YoY Change	6.33%	8.17%	9.33%
Gross Profit	$1.181M	$1.350M	$1.268M
YoY Change	-12.46%	6.48%	10.27%
Gross Profit Margin	45.68%	45.26%	45.65%
Selling, General & Admin	$2.511M	$2.892M	$2.688M
YoY Change	1.1%	7.57%	-9.17%
% of Gross Profit	212.57%	214.2%	212.04%
Research & Development	$895.9K	$684.5K	$732.0K
YoY Change	59.95%	-6.49%	22.04%
% of Gross Profit	75.86%	50.7%	57.74%
Depreciation & Amortization	$188.2K	$190.6K	$106.4K
YoY Change	-0.37%	79.14%	-14.74%
% of Gross Profit	15.94%	14.12%	8.39%
Operating Expenses	$3.406M	$3.576M	$3.420M
YoY Change	11.93%	4.56%	-3.91%
Operating Profit	-$2.225M	-$2.226M	-$2.153M
YoY Change	31.35%	3.42%	-10.68%
Interest Expense	$19.00K	$37.00K	$27.50K
YoY Change		34.55%	154.63%
% of Operating Profit
Other Income/Expense, Net	$24.30K	$41.10K	-$178.4K
YoY Change	62.0%	-123.04%	-132.48%
Pretax Income	-$2.201M	-$2.185M	-$2.303M
YoY Change	28.78%	-5.14%	24.52%
Income Tax	$0.00	$108.8K	-$298.3K
% Of Pretax Income
Net Earnings	-$2.201M	-$2.292M	-$2.004M
YoY Change	70.36%	14.37%	47.24%
Net Earnings / Revenue	-85.13%	-76.85%	-72.17%
Basic Earnings Per Share
Diluted Earnings Per Share	-$0.31	-$0.33	-$289.7K
COMMON SHARES
Basic Shares Outstanding	7.004M shares	7.004M shares	7.004M shares
Diluted Shares Outstanding	7.004M shares	7.004M shares	7.004M shares

Balance Sheet

Concept	2023 Q3	2023 Q2	2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.325M	$2.489M	$9.363M
YoY Change	-82.87%	-73.42%	-30.23%
Cash & Equivalents	$515.4K	$644.5K	$2.971M
Short-Term Investments	$809.6K	$1.844M	$6.392M
Other Short-Term Assets	$619.6K	$537.3K	$547.8K
YoY Change	21.39%	-1.92%	34.86%
Inventory	$5.282M	$5.288M	$4.696M
Prepaid Expenses
Receivables	$1.293M	$1.088M	$1.501M
Other Receivables	$52.70K	$52.70K	$161.1K
Total Short-Term Assets	$8.572M	$9.455M	$16.27M
YoY Change	-40.9%	-41.89%	-11.73%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.094M	$1.168M	$1.006M
YoY Change	2.6%	16.19%	143.72%
Goodwill	$115.3K	$115.3K	$4.395M
YoY Change	-97.38%	-97.38%	0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$58.20K	$58.20K	$62.40K
YoY Change	-6.73%	-6.73%	14.92%
Total Long-Term Assets	$4.476M	$4.745M	$12.76M
YoY Change	-65.76%	-62.82%	20.68%
TOTAL ASSETS
Total Short-Term Assets	$8.572M	$9.455M	$16.27M
Total Long-Term Assets	$4.476M	$4.745M	$12.76M
Total Assets	$13.05M	$14.20M	$29.03M
YoY Change	-52.68%	-51.09%	0.09%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.095M	$640.8K	$1.106M
YoY Change	141.87%	-42.06%	143.86%
Accrued Expenses	$810.8K	$926.2K	$796.0K
YoY Change	6.33%	16.36%	25.65%
Deferred Revenue
YoY Change
Short-Term Debt	$13.30K	$0.00	$0.00
YoY Change	-84.17%		-100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$2.183M	$1.714M	$2.230M
YoY Change	37.83%	-23.15%	-2.48%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$987.3K	$1.157M	$0.00
YoY Change	-18.99%		-100.0%
Total Long-Term Liabilities	$987.3K	$1.157M	$0.00
YoY Change	-18.99%		-100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.183M	$1.714M	$2.230M
Total Long-Term Liabilities	$987.3K	$1.157M	$0.00
Total Liabilities	$3.170M	$2.871M	$3.470M
YoY Change	13.12%	-17.26%	24.74%
SHAREHOLDERS EQUITY
Retained Earnings	-$25.26M	-$23.06M	-$6.296M
YoY Change	232.94%	266.31%	866.9%
Common Stock	$350.2K	$350.2K	$32.02M
YoY Change	-98.93%	-98.91%	18.85%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$0.00	$0.00	$52.40K
YoY Change	-100.0%	-100.0%	0.0%
Treasury Stock Shares			19.80K shares
Shareholders Equity	$9.878M	$11.33M	$25.56M
YoY Change
Total Liabilities & Shareholders Equity	$13.05M	$14.20M	$29.03M
YoY Change	-52.68%	-51.09%	0.09%

Cashflow Statement

Concept	2023 Q3	2023 Q2	2022 Q2
OPERATING ACTIVITIES
Net Income	-$2.201M	-$2.292M	-$2.004M
YoY Change	70.36%	14.37%	47.24%
Depreciation, Depletion And Amortization	$188.2K	$190.6K	$106.4K
YoY Change	-0.37%	79.14%	-14.74%
Cash From Operating Activities	-$1.162M	-$1.915M	-$1.817M
YoY Change	-20.76%	5.42%	156.22%
INVESTING ACTIVITIES
Capital Expenditures	$11.70K	$60.40K	-$420.2K
YoY Change	-92.69%	-114.37%	2701.33%
Acquisitions
YoY Change
Other Investing Activities	$1.040M	$1.539M	$1.220M
YoY Change	1.26%	26.22%	-119.97%
Cash From Investing Activities	$1.028M	$1.479M	$799.3K
YoY Change	18.61%	85.02%	-113.06%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	13.30K	0.000	-98.80K
YoY Change	-84.17%	-100.0%	-100.62%
NET CHANGE
Cash From Operating Activities	-1.162M	-1.915M	-1.817M
Cash From Investing Activities	1.028M	1.479M	799.3K
Cash From Financing Activities	13.30K	0.000	-98.80K
Net Change In Cash	-120.7K	-436.1K	-1.116M
YoY Change	-77.37%	-60.93%	-112.32%
FREE CASH FLOW
Cash From Operating Activities	-$1.162M	-$1.915M	-$1.817M
Capital Expenditures	$11.70K	$60.40K	-$420.2K
Free Cash Flow	-$1.174M	-$1.975M	-$1.396M
YoY Change	-27.84%	41.46%	101.21%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	1000	usd
CY2022Q4	scnd	Available For Sale Securities Current Amount AvailableForSaleSecuritiesCurrentAmount	4272100	usd
CY2022Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	6199200	usd
CY2022Q4	scnd	Cost Of Financial Instruments CostOfFinancialInstruments	4417400	usd
CY2022Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	3703900	usd
CY2023Q2	us-gaap	Adjustment For Amortization AdjustmentForAmortization	127800	usd
CY2022Q2	us-gaap	Adjustment For Amortization AdjustmentForAmortization	134400	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	258800	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	506100	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	371500	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	193800	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	92600	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	82400	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1505200	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	269600	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	266600	usd
CY2023Q2	scnd	Lessee Operating Lease Liability Payments Due Yearsix LesseeOperatingLeaseLiabilityPaymentsDueYearsix	274600	usd
CY2023Q2	scnd	Thereafter Thereafter	201000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	1470500	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	175000	usd
CY2023Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	1295500	usd
CY2023Q2	scnd	Weighted Average Common Shares Outstanding WeightedAverageCommonSharesOutstanding	7003599	shares
	dei	Entity Central Index Key EntityCentralIndexKey	0000087802
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Security12g Title Security12gTitle	Common stock, $.05 par value
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	33600	usd
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.05
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	20000000	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	7003599	shares
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-06-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	0-6658
	dei	Entity Registrant Name EntityRegistrantName	SCIENTIFIC INDUSTRIES, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	04-2217279
	dei	Entity Address Address Line1 EntityAddressAddressLine1	80 Orville Drive
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 102
	dei	Entity Address City Or Town EntityAddressCityOrTown	Bohemia
	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	11716
	dei	City Area Code CityAreaCode	631
	dei	Local Phone Number LocalPhoneNumber	567-4700
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	7003599	shares
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	644500	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1927100	usd
CY2023Q2	us-gaap	Trading Securities TradingSecurities	1844100	usd
CY2022Q4	us-gaap	Trading Securities TradingSecurities	4272100	usd
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	33600	usd
CY2023Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1087500	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1312900	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	5288400	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	4859600	usd
CY2023Q2	us-gaap	Income Tax Receivable IncomeTaxReceivable	52700	usd
CY2022Q4	us-gaap	Income Tax Receivable IncomeTaxReceivable	161400	usd
CY2023Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	537300	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	456800	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	9454500	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	12989900	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1168400	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1163200	usd
CY2023Q2	us-gaap	Goodwill Goodwill	115300	usd
CY2022Q4	us-gaap	Goodwill Goodwill	115300	usd
CY2023Q2	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	1505200	usd
CY2022Q4	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	1763000	usd
CY2023Q2	us-gaap	Inventory Noncurrent InventoryNoncurrent	659500	usd
CY2022Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	606000	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1238800	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1373600	usd
CY2023Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	58200	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	58200	usd
CY2023Q2	us-gaap	Assets Assets	14199900	usd
CY2022Q4	us-gaap	Assets Assets	18069200	usd
CY2023Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	640800	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	887300	usd
CY2023Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	926200	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	821800	usd
CY2023Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	8300	usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	134400	usd
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	138600	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	276900	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	1713900	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2120400	usd
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1156900	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1156200	usd
CY2023Q2	us-gaap	Liabilities Liabilities	2870800	usd
CY2022Q4	us-gaap	Liabilities Liabilities	3276600	usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.05
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	20000000	shares
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	7003599	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	7023401	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	7003599	shares
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	350200	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	351200	usd
CY2023Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	34036700	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	32900800	usd
CY2023Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	3300	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-8400	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-23061100	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-18398600	usd
CY2023Q2	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	0	shares
CY2022Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	19802	shares
CY2023Q2	us-gaap	Treasury Stock Value TreasuryStockValue	0	usd
CY2022Q4	us-gaap	Treasury Stock Value TreasuryStockValue	52400	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	11329100	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	14792600	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	14199900	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	18069200	usd
CY2023Q2	us-gaap	Revenues Revenues	2982500	usd
CY2022Q2	us-gaap	Revenues Revenues	2777000	usd
	us-gaap	Revenues Revenues	5787900	usd
	us-gaap	Revenues Revenues	5641900	usd
CY2023Q2	us-gaap	Cost Of Revenue CostOfRevenue	1632500	usd
CY2022Q2	us-gaap	Cost Of Revenue CostOfRevenue	1509200	usd
	us-gaap	Cost Of Revenue CostOfRevenue	3099900	usd
	us-gaap	Cost Of Revenue CostOfRevenue	2827500	usd
CY2023Q2	us-gaap	Gross Profit GrossProfit	1350000	usd
CY2022Q2	us-gaap	Gross Profit GrossProfit	1267800	usd
	us-gaap	Gross Profit GrossProfit	2688000	usd
	us-gaap	Gross Profit GrossProfit	2814400	usd
CY2023Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1299900	usd
CY2022Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1374300	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2869200	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2984700	usd
CY2023Q2	us-gaap	Selling Expense SellingExpense	1591800	usd
CY2022Q2	us-gaap	Selling Expense SellingExpense	1314000	usd
	us-gaap	Selling Expense SellingExpense	3036600	usd
	us-gaap	Selling Expense SellingExpense	2368000	usd
CY2023Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	684500	usd
CY2022Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	732000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1476000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1356500	usd
CY2023Q2	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	0	usd
CY2022Q2	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	4280100	usd
	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	0	usd
	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	4280100	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	3576200	usd
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	7700400	usd
	us-gaap	Operating Expenses OperatingExpenses	7381800	usd
	us-gaap	Operating Expenses OperatingExpenses	10989300	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-2226200	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-6432600	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-4693800	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-8174900	usd
CY2023Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	4100	usd
CY2022Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-178400	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	90400	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-281100	usd
CY2023Q2	us-gaap	Interest Income Other InterestIncomeOther	37000	usd
CY2022Q2	us-gaap	Interest Income Other InterestIncomeOther	27500	usd
	us-gaap	Interest Income Other InterestIncomeOther	46400	usd
	us-gaap	Interest Income Other InterestIncomeOther	27900	usd
CY2023Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	41100	usd
CY2022Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-150900	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	136800	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-253200	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2185100	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-6583500	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4557000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-8428100	usd
CY2023Q2	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	108800	usd
CY2022Q2	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-4100	usd
	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	108800	usd
	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-99200	usd
CY2023Q2	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	usd
CY2022Q2	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	3449400	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	3227300	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	108800	usd
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3445300	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	108800	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3128100	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-2293900	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-10028800	usd
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-4665800	usd
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-11556200	usd
CY2023Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	1900	usd
	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	3300	usd
	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-6600	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-2292000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-10027800	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4662500	usd
	us-gaap	Net Income Loss NetIncomeLoss	-11562800	usd
CY2023Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-2100	usd
CY2022Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-5100	usd
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	1600	usd
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-9800	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-30100	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	4300	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	10100	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-190200	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-32200	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-800	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	11700	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-200000	usd
CY2023Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2324200	usd
CY2022Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-10028600	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-4650800	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-11762800	usd
CY2023Q2	scnd	Income Loss From Continuing Operations Per Basic And Diluted Shares IncomeLossFromContinuingOperationsPerBasicAndDilutedShares	-0.33
CY2022Q2	scnd	Income Loss From Continuing Operations Per Basic And Diluted Shares IncomeLossFromContinuingOperationsPerBasicAndDilutedShares	-1.43
	scnd	Income Loss From Continuing Operations Per Basic And Diluted Shares IncomeLossFromContinuingOperationsPerBasicAndDilutedShares	-0.67
	scnd	Income Loss From Continuing Operations Per Basic And Diluted Shares IncomeLossFromContinuingOperationsPerBasicAndDilutedShares	-1.69
CY2023Q2	scnd	Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Shares IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShares	0
CY2022Q2	scnd	Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Shares IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShares	0
	scnd	Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Shares IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShares	0
	scnd	Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Shares IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShares	0
CY2023Q2	scnd	Earning Per Share Basic And Diluted EarningPerShareBasicAndDiluted	-0.33
CY2022Q2	scnd	Earning Per Share Basic And Diluted EarningPerShareBasicAndDiluted	-1.43
	scnd	Earning Per Share Basic And Diluted EarningPerShareBasicAndDiluted	-0.67
	scnd	Earning Per Share Basic And Diluted EarningPerShareBasicAndDiluted	-1.69
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	14792600	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-2370500	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	40200	usd
CY2023Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	3700	usd
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	1633300	usd
	us-gaap	Proceeds From Sale Of Longterm Investments ProceedsFromSaleOfLongtermInvestments	3420300	usd
	us-gaap	Proceeds From Sale Of Longterm Investments ProceedsFromSaleOfLongtermInvestments	1865500	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	106200	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	594200	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	0	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	602600	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	13068600	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-2292000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-30100	usd
CY2023Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-2100	usd
CY2023Q2	us-gaap	Treasury Stock Retired Par Value Method Amount TreasuryStockRetiredParValueMethodAmount	0	usd
CY2023Q2	us-gaap	Share Based Compensation ShareBasedCompensation	584700	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	11329100	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	25489500	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-1535000	usd
CY2022Q1	scnd	Issuance Of Common Stock And Warrants Net Of Issuance Costs Amount IssuanceOfCommonStockAndWarrantsNetOfIssuanceCostsAmount	2727200	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-194500	usd
CY2022Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-4700	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	653700	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	27136200	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-10027800	usd
CY2022Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-5100	usd
CY2022Q2	us-gaap	Share Based Compensation ShareBasedCompensation	430500	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	17538100	usd
	us-gaap	Profit Loss ProfitLoss	-4662500	usd
	us-gaap	Profit Loss ProfitLoss	-11562800	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	378500	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	360900	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1187300	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1084200	usd
	scnd	Change In Fair Value Of Contingent Consideration ChangeInFairValueOfContingentConsideration	0	usd
	scnd	Change In Fair Value Of Contingent Consideration ChangeInFairValueOfContingentConsideration	17500	usd
	us-gaap	Loss On Sale Of Investments LossOnSaleOfInvestments	105000	usd
	us-gaap	Loss On Sale Of Investments LossOnSaleOfInvestments	36700	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-155100	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	201100	usd
	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	0	usd
	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	3223300	usd
	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	0	usd
	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	4280100	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	188200	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-156600	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-471600	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-1081300	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-77100	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	21900	usd
	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	108800	usd
	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-95100	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	0	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	100	usd
	scnd	Increase Decrease In Right Of Use Assets IncreaseDecreaseInRightOfUseAssets	136000	usd
	scnd	Increase Decrease In Right Of Use Assets IncreaseDecreaseInRightOfUseAssets	-808600	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-270100	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	170300	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	137900	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	212200	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-126100	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	29000	usd
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	0	usd
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	0	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-138900	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	807900	usd
	scnd	Increase Decrease In Adjustments IncreaseDecreaseInAdjustments	-512900	usd
	scnd	Increase Decrease In Adjustments IncreaseDecreaseInAdjustments	-900200	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3659700	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3259200	usd
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	941500	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	500	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	2372600	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-362500	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	3000000	usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	272800	usd
	scnd	Payments Of Contingent Consideration PaymentsOfContingentConsideration	98800	usd
	us-gaap	Repayments Of Bank Debt RepaymentsOfBankDebt	0	usd
	us-gaap	Repayments Of Bank Debt RepaymentsOfBankDebt	158300	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	0	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2470100	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4500	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-174300	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1282600	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1325900	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1927100	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4297000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	644500	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2971100	usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	usd
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	0	usd
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	69600	usd
	scnd	Record Lease Liabilities RecordLeaseLiabilities	0	usd
	scnd	Record Lease Liabilities RecordLeaseLiabilities	69100	usd
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	644500	usd
CY2023Q2	scnd	Available For Sale Securities Current Amount AvailableForSaleSecuritiesCurrentAmount	1844100	usd
CY2023Q2	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	2488600	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1927100	usd
CY2023Q2	scnd	Cost Of Financial Instruments CostOfFinancialInstruments	1715600	usd
CY2023Q2	us-gaap	Financial Instruments Owned At Fair Value FinancialInstrumentsOwnedAtFairValue	1844100	usd
CY2023Q2	scnd	Unrealized Holding Gain Loss UnrealizedHoldingGainLoss	128500	usd
CY2022Q4	us-gaap	Financial Instruments Owned At Fair Value FinancialInstrumentsOwnedAtFairValue	4272100	usd
CY2022Q4	scnd	Unrealized Holding Gain Loss UnrealizedHoldingGainLoss	-145300	usd
CY2023Q2	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	3804400	usd
CY2023Q2	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	94900	usd
CY2022Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	66700	usd
CY2023Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	2048600	usd
CY2022Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	1695000	usd
CY2023Q2	scnd	Inventory Net1 InventoryNet1	5947900	usd
CY2022Q4	scnd	Inventory Net1 InventoryNet1	5465600	usd
CY2023Q2	scnd	Inventories Current Assets InventoriesCurrentAssets	5288400	usd
CY2022Q4	scnd	Inventories Current Assets InventoriesCurrentAssets	4859600	usd
CY2023Q2	scnd	Inventories Noncurrent Assets InventoriesNoncurrentAssets	659500	usd
CY2022Q4	scnd	Inventories Noncurrent Assets InventoriesNoncurrentAssets	606000	usd
CY2023Q2	us-gaap	Goodwill Goodwill	115300	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	4341600	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	2836400	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1505200	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	4341600	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	2578600	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1763000	usd
	us-gaap	Adjustment For Amortization AdjustmentForAmortization	257800	usd
	us-gaap	Adjustment For Amortization AdjustmentForAmortization	269000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	161800	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	296900	usd
CY2022Q2	scnd	Weighted Average Common Shares Outstanding WeightedAverageCommonSharesOutstanding	7003599	shares
	scnd	Weighted Average Common Shares Outstanding WeightedAverageCommonSharesOutstanding	7003599	shares
	scnd	Weighted Average Common Shares Outstanding WeightedAverageCommonSharesOutstanding	6819771	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	7003599	shares
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	7003599	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	7003599	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6819771	shares
CY2023Q2	scnd	Income Loss From Continuing Operations Per Basic And Diluted Share Continuing Operations IncomeLossFromContinuingOperationsPerBasicAndDilutedShareContinuingOperations	-0.33
CY2022Q2	scnd	Income Loss From Continuing Operations Per Basic And Diluted Share Continuing Operations IncomeLossFromContinuingOperationsPerBasicAndDilutedShareContinuingOperations	-1.43
	scnd	Income Loss From Continuing Operations Per Basic And Diluted Share Continuing Operations IncomeLossFromContinuingOperationsPerBasicAndDilutedShareContinuingOperations	-0.67
	scnd	Income Loss From Continuing Operations Per Basic And Diluted Share Continuing Operations IncomeLossFromContinuingOperationsPerBasicAndDilutedShareContinuingOperations	-1.69
CY2023Q2	scnd	Income Loss From Discontinued Operation Net Of Tax Per Basic And Diluted Share Discontinued Operation IncomeLossFromDiscontinuedOperationNetOfTaxPerBasicAndDilutedShareDiscontinuedOperation	0
CY2022Q2	scnd	Income Loss From Discontinued Operation Net Of Tax Per Basic And Diluted Share Discontinued Operation IncomeLossFromDiscontinuedOperationNetOfTaxPerBasicAndDilutedShareDiscontinuedOperation	0
	scnd	Income Loss From Discontinued Operation Net Of Tax Per Basic And Diluted Share Discontinued Operation IncomeLossFromDiscontinuedOperationNetOfTaxPerBasicAndDilutedShareDiscontinuedOperation	0
	scnd	Income Loss From Discontinued Operation Net Of Tax Per Basic And Diluted Share Discontinued Operation IncomeLossFromDiscontinuedOperationNetOfTaxPerBasicAndDilutedShareDiscontinuedOperation	0
CY2023Q2	scnd	Consolidated Operations Earnings Per Share Basic And Diluted ConsolidatedOperationsEarningsPerShareBasicAndDiluted	-0.33
CY2022Q2	scnd	Consolidated Operations Earnings Per Share Basic And Diluted ConsolidatedOperationsEarningsPerShareBasicAndDiluted	-1.43
	scnd	Consolidated Operations Earnings Per Share Basic And Diluted ConsolidatedOperationsEarningsPerShareBasicAndDiluted	-0.67
	scnd	Consolidated Operations Earnings Per Share Basic And Diluted ConsolidatedOperationsEarningsPerShareBasicAndDiluted	-1.69

Files In Submission

Name	View Source	Status
0001654954-23-010777-index-headers.html	Edgar Link	pending
0001654954-23-010777-index.html	Edgar Link	pending
0001654954-23-010777.txt	Edgar Link	pending
0001654954-23-010777-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
scnd-20230630.xsd	Edgar Link	pending
scnd_10q.htm	Edgar Link	pending
scnd_ex311.htm	Edgar Link	pending
scnd_ex312.htm	Edgar Link	pending
scnd_ex321.htm	Edgar Link	pending
scnd_ex322.htm	Edgar Link	pending
Show.js	Edgar Link	pending
scnd-20230630_cal.xml	Edgar Link	unprocessable
scnd-20230630_lab.xml	Edgar Link	unprocessable
scnd-20230630_pre.xml	Edgar Link	unprocessable
scnd-20230630_def.xml	Edgar Link	unprocessable
scnd_10q_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SCND
SCIENTIFIC INDUSTRIES INC Stock $scnd

2023 Q3 Form 10-Q Financial Statement

#000165495423010777 Filed on August 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SCND SCIENTIFIC INDUSTRIES INC Stock $scnd

2023 Q3 Form 10-Q Financial Statement

#000165495423010777 Filed on August 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SCND
SCIENTIFIC INDUSTRIES INC Stock $scnd